Abstract
The rapid development of scientific communication approaches for environmental surveillance data with online information dashboards has been done in the absence of a global organizing body during the coronavirus disease 2019 pandemic. We aim to make a case for standardization of dashboards presenting SARS-CoV-2 wastewater data. The list of dashboards was compiled as of March 31, 2022. The 127 dashboards reviewed represented 27 countries using a range of line/bar graphs, maps, and tables with symbol presentation. We identified 96 separate units of measure for the wastewater SARS-CoV-2 data. There was also inconsistency in using linear or log scale. Twenty-five percent of dashboards presented SARS-CoV-2 variant monitoring. Only 30% (38/125) of dashboards provided downloadable source data. There is great opportunity to improve scientific communication though the adoption of uniform data presentation conventions or standards for this field.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by The Rockefeller Foundation, the James Graham Brown Foundation, the Owsley Brown II Family Foundation, PATH, National Science Foundation (#2037834), Center for Information Technology Research in the Interest of Society (CITRIS) and the Banatao Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Dashboards used in the analysis are available online public records, links of which are provided in Supplement A.
